Aquatic Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $488K | Buy |
23,965
+12,989
| +118% | +$264K | 0.01% | 828 |
|
|
2025
Q1 | $199K | Buy |
10,976
+6,196
| +130% | +$112K | 0.01% | 934 |
|
|
2024
Q4 | $121K | Buy |
+4,780
| New | +$121K | ﹤0.01% | 1035 |
|
|
2024
Q2 | – | Sell |
-4,100
| Closed | -$172K | – | 1284 |
|
|
2024
Q1 | $172K | Buy |
4,100
+700
| +21% | +$29.4K | 0.01% | 800 |
|
|
2023
Q4 | $135K | Buy |
+3,400
| New | +$135K | ﹤0.01% | 941 |
|
|
2023
Q2 | – | Sell |
-14,900
| Closed | -$536K | – | 1387 |
|
|
2023
Q1 | $536K | Buy |
+14,900
| New | +$536K | 0.03% | 399 |
|
|
2022
Q4 | – | Sell |
-15,500
| Closed | -$436K | – | 1427 |
|
|
2022
Q3 | $436K | Buy |
+15,500
| New | +$436K | 0.04% | 442 |
|